On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

TD Cowen analyst Phil Nadeau maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report) today. The company’s shares opened ...

Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for J. M. Smucker (NYSE:SJM) from Buy to Hold.

Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) from Hold to ...

TD Cowen analyst John Kernan raised the firm’s price target on Dick’s Sporting to $294 from $270 and keeps a Buy rating on the shares. TD’s ...

Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD Cowen report on the big investment themes of 2025, including shifting ...

“Two-thousand-twenty-four was a tough year for staples stocks, and 2025 is shaping up to be even tougher,” says TD Cowen ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...

The S&P 500 gained 0.55% to close at 5,975.38. The Nasdaq Composite advanced 1.24% to end at 19,864.98. The Dow Jones ...

Shares of American Airlines surged Monday after brokerages Jefferies and TD Cowen upgraded and raised their price targets on ...